Adeia Inc header image

Adeia Inc

ADEA

Equity

ISIN null / Valor 121680853

NASDAQ (2025-11-17)
USD 12.41-3.50%

Adeia Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Adeia Inc is a company that focuses on shaping entertainment experiences and enhancing devices in a connected world. Their patented innovations cover various aspects of the entertainment experience, including guidance, discovery, search, recommendations, DVR, VOD, OTT, multi-screen, personalization, data analytics, advertising, imaging, content storage, and high-performance computing. Adeia licenses its innovations for use with traditional linear television and increasingly with OTT, direct-to-consumer, and social media services. They believe in the growth of video consumption and the evolution of how consumers explore and experience video, presenting new opportunities for developing patentable innovations and expanding the industries they serve.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (17.10.2025):

Adeia Inc. reported its financial results for the second quarter of 2025, demonstrating significant growth in net income and maintaining a strong balance sheet. The company continues to invest in research and development while managing its operating expenses effectively.

Revenue Growth

For the three months ended June 30, 2025, Adeia Inc. reported revenue of $85.7 million, a slight decrease from $87.3 million in the same period the previous year. However, for the six months ended June 30, 2025, revenue increased to $173.4 million compared to $170.8 million in 2024.

Net Income Surge

The net income for the three months ended June 30, 2025, was $16.7 million, up from $8.4 million in Q2 2024. For the six-month period, net income surged to $28.5 million, significantly higher than $9.3 million reported in the previous year.

Operating Expenses Management

Total operating expenses for the three months ended June 30, 2025, were $69.3 million, compared to $63.7 million in the same quarter last year. Over six months, operating expenses were $134.2 million, up from $127.7 million in 2024, reflecting increased investments in research and development and other administrative costs.

Cash Flow and Financing

Adeia Inc. generated $80.3 million in net cash from operating activities for the six months ended June 30, 2025, compared to $90.7 million in the previous year. The company used $68.7 million in financing activities, including dividends and debt repayments.

Strong Balance Sheet

As of June 30, 2025, Adeia Inc. reported total assets of $1.08 billion and total liabilities of $679.98 million. Stockholders' equity increased to $402.9 million from $396.6 million at the end of 2024, reflecting the company's robust financial position.

Summarized from source with an LLMView Source

Key figures

6.98%1Y
26.2%3Y
%5Y

Performance

50.4%1Y
44.2%3Y
45.5%5Y

Volatility

Market cap

1357 M

Market cap (USD)

Daily traded volume (Shares)

739,659

Daily traded volume (Shares)

1 day high/low

13.95 / 13.5

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Pegasystems Inc
Pegasystems Inc Pegasystems Inc Valor: 503997
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.87%USD 54.65
Halozyme Therapeutics Inc
Halozyme Therapeutics Inc Halozyme Therapeutics Inc Valor: 1814799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 70.56
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc Valor: 57410241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%USD 74.17
Flywire Corp
Flywire Corp Flywire Corp Valor: 111444572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.51%USD 13.57
Sezzle Inc
Sezzle Inc Sezzle Inc Valor: 129105133
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 50.97
PAR Technology Corporation
PAR Technology Corporation PAR Technology Corporation Valor: 960461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.66%USD 36.70
Toast Inc
Toast Inc Toast Inc Valor: 113470913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.31%USD 34.71
Sportradar Group AG
Sportradar Group AG Sportradar Group AG Valor: 113423966
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.33%USD 21.81
Duolingo Inc
Duolingo Inc Duolingo Inc Valor: 112404331
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.67%USD 178.27
STEMMER IMAGING AG
STEMMER IMAGING AG STEMMER IMAGING AG Valor: 40430134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 59.00